Document Detail

Circulating MicroRNAs as Potential Risk Biomarkers for Hematoma Enlargement after Intracerebral Hemorrhage.
MedLine Citation:
PMID:  23190933     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND AND PURPOSE: MicroRNAs have recently been shown to regulate the downstream bioprocesses of intracerebral hemorrhage. The aim of this study was to investigate whether miRNAs can be used as biomarkers to predict secondary hematoma enlargement (HE) in patients with ICH.
METHODS: Consecutively, 79 ICH patients admitted within 6 h of symptom onset and 30 healthy individuals were enrolled in this study. Whole-genome miRNA expression profiles were generated in 32 patients (HE/non-HE: 14/18). Representative differentially expressed miRNAs were measured in all cases (HE/non-HE: 30/49) and normal controls (n = 30) by real-time PCR.
RESULTS: Thirty miRNAs showed differential expressions in the plasma samples from patients with HE as compared with the non-HE controls. Compared to the hierarchical cluster analysis with all probes on microarray, all patients were separated into two main branches with only four exceptions by 30 differentially expressed miRNAs, improving the overall accuracy from 47.62 to 77.78% in the HE and 72.73 to 100% in the non-HE group. Further support vector machine (SVM) test can discriminate the two groups with 100% accuracy with 10 differentially expressed miRNAs.
CONCLUSIONS: We demonstrated that multiple miRNAs are differentially expressed in the plasma of ICH patients with or without HE and may serve as circulating biomarkers for predicting HE after ICH.
Hong-Wei Zheng; Yi-Long Wang; Jin-Xi Lin; Na Li; Xing-Quan Zhao; Gai-Fen Liu; Li-Ping Liu; Yan Jiao; Wei-Kuan Gu; David Z Wang; Yong-Jun Wang
Related Documents :
24252013 - Clinicopathological features of igg4-related disease complicated with orbital involvement.
23178273 - The role of anthropometric characteristics in idiopathic carpal tunnel syndrome.
21435003 - Aberrant expression of p53, p16(ink4a) and ki-67 as basic biomarker for malignant progr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  CNS neuroscience & therapeutics     Volume:  18     ISSN:  1755-5949     ISO Abbreviation:  CNS Neurosci Ther     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101473265     Medline TA:  CNS Neurosci Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1003-11     Citation Subset:  IM    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Department of Neurology, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional exercise after total hip replacement (FEATHER) a randomised control trial.
Next Document:  Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.